Alexion Pharmaceuticals, Inc (NASDAQ:ALXN) achieved its new 52 week high price of $80.97 where it was opened at $80.35 up 1.10 points or +1.41% by closing at $78.88. ALXN transacted shares during the day were over 1.16 million shares however it has an average volume of 1.16 million shares.

Alexion Pharmaceuticals, Inc (NASDAQ:ALXN) (Alexion) is a biopharmaceutical company engaged in the discovery, development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states. Alexion Pharmaceuticals, Inc achieved its new 52 week high price of $72.25 where it was opened at $71.46 UP 0.52 points or +0.73% by closing at $71.50.

PDI, Inc. (Nasdaq:PDII) announced that Nancy Lurker, the company's chief executive officer, is scheduled to present at the UBS Global Life Sciences Conference at 1:00 pm ET on September 19, 2011 at the Grand Hyatt New York.

PDI, Inc. provides outsourced promotional services to various companies in the pharmaceutical, biotechnology, and healthcare industries in the United States.

****